Thyroid Disorders in Patients Treated with Dimethyl Fumarate for Multiple Sclerosis: A Retrospective Observational Study

Background: Dimethyl fumarate (DMF), a drug used for the treatment of multiple sclerosis (MS) and psoriasis, has been shown to activate the Keap1/Nrf2 antioxidant response. Nrf2 exerts pleiotropic roles in the thyroid gland; among others, single nucleotide polymorphisms (SNPs) in the gene encoding N...

Descripción completa

Detalles Bibliográficos
Autores principales: Renaud, Cédric O., Ziros, Panos G., Mathias, Amandine, Pot, Caroline, Sykiotis, Gerasimos P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138003/
https://www.ncbi.nlm.nih.gov/pubmed/35624879
http://dx.doi.org/10.3390/antiox11051015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138003/
https://www.ncbi.nlm.nih.gov/pubmed/35624879
http://dx.doi.org/10.3390/antiox11051015

Ejemplares similares